نتایج جستجو برای: 4-Aminopyridine (4-AP)

تعداد نتایج: 1326732  

Journal: :Medico-Legal Update 2021

Multiple sclerosis (MS) is a neurological disorder characterized by complex array of symptoms affectingmovement and the senses. It an inflammatory disease central nervous system (CNS) causes injuryin myelin sheaths, leading to demyelination thus, consequently, series neurologically dysfunctionknown as relapses. 4-Aminopyridine used in treatment MS patients selective voltage blockerchannel. The ...

2013
Anthony Caggiano Andrew Blight Tom J. Parry

BACKGROUND Dalfampridine (4-aminopyridine; 4-AP) is a potassium channel blocker that has been available in the United States as a treatment to improve walking in patients with multiple sclerosis. 4-AP is well-characterized in vitro with regard to inhibition of neuronal potassium channels, but the potential contribution of its metabolites to clinical activity has not been determined. This study ...

Journal: :Journal of Synthetic Organic Chemistry, Japan 1990

Journal: :The Journal of pharmacology and experimental therapeutics 2000
R Brandsgaard J E Barrett S Rosenzweig-Lipson

The discriminative stimulus (DS) effects of 4-aminopyridine (4-AP) were evaluated in 36 male Sprague-Dawley rats that were trained to discriminate 4-AP from saline in a standard two-lever food reinforced drug discrimination procedure. 4-AP along with its structural analogs 3-aminopyridine (3-AP), 2-aminopyridine (2-AP), and 2,3-diaminopyridine (2,3-DIAP) produced dose-dependent increases in the...

Ali Reza Taji Fatemeh Forouzanfar Hamid Reza Sadeghnia, Hossein Hosseinzadeh,

Objective(s): K+ channel blocker 4-aminopyridine (4-AP) stimulates the release of glutamate from nerve terminals and induces seizures. Berberine as a potential herbal drug exerts several pharmacological actions on the central nervous system including anxiolytic, anticonvulsant, and neuroprotective properties. The present study aimed to investigate the effect of berberine on seizure onset and ti...

Journal: :Naunyn-Schmiedeberg's archives of pharmacology 1980
M Galvan P Grafe G ten Bruggencate

Responses to bath-applications of 4-aminopyridine(4-AP) and gamma-aminobutyric acid (GABA) were recorded intracellularly from neurones in the rat isolated superior cervical ganglion. 4-aminopyridine (0.1-1.0 mmol/l) usually induced spontaneous action potentials and excitatory postsynaptic potentials (EPSPs), which were blocked by hexamethonium. Membrane potential was unchanged; spike duration w...

Journal: :Acta Crystallographica Section E Structure Reports Online 2010

Introduction: Glioblastoma is an aggressive malignancy of human brain with poorly understood pathogenesis. Voltage-gated potassium (Kv) channels and Matrix metalloproteinases (MMPs) are highly expressed in malignant tumors and involved in the progression and metastasis of glioblastoma. The purpose of this study was to determine whether a voltage-dependent potassium channel blocker could modulat...

Journal: :Journal of neurophysiology 2010
Wenjing Sun Daniel Smith Yan Fu Ji-Xin Cheng Steven Bryn Richard Borgens Riyi Shi

We have demonstrated that 4-aminopyridine-3-methanol (4-AP-3-MeOH), a 4-aminopyridine derivative, significantly restores axonal conduction in stretched spinal cord white-matter strips and shows no preference in restoring large and small axons. This compound is 10 times more potent when compared with 4-AP and other derivatives in restoring axonal conduction. Unlike 4-AP, 4-AP-3-MeOH can restore ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید